Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record.

Hematopoietic Cytokines - on the Verge of Conquering Neurology

Tonges, Lars, M. Schlachetzki, Johannes, Weishaupt, Jochen, Bahr, Mathias · 2007 · Current Molecular Medicine

Abstract

Two hematopoietic cytokines are currently gaining increasing attention within neurological research. Erythropoietin (EPO) and granulocyte-colony stimulating factor (G-CSF) have long been known for their ability to induce the proliferation of certain populations of hematopoietic lineage cells. However, it has recently been found that EPO, G-CSF, and their respective receptors are also expressed in the human central nervous system (CNS) and may be an important part of the brain's endogenous system of protection. Both hematopoietic cytokines have been shown to have neuroprotective potential in a variety of animal disease models both in vitro and in vivo, through the inhibition of apoptosis, induction of angiogenesis, exertion of anti-inflammatory and neurotrophic effects, as well as by the enhancement of neurogenesis. EPO and G-CSF have been extensively studied in the context of hematological disorders and have recently been successfully applied in the first clinical trials in stroke patients. Intravenous high-dose EPO therapy was associated with an improvement in the clinical outcome and preclinical studies with intravenous high-dose G-CSF therapy have clearly shown that it has considerable neuroprotective potential in the acute, as well as in the chronic phase of stroke. In this review, the current knowledge of the neuroprotective mechanisms of EPO and G-CSF is summarized with regard to in vitro and in vivo data. Focus is placed on the role of EPO in neurological disease models with an emphasis on its influence on functional outcome. New experimental results are assessed in detail and correlated with the findings of recent clinical studies.

Overview

Integrity signals

Registry

Crossref · 10.2174/156652407780059186

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 27

Metadata

Authors
Tonges, L., M. Schlachetzki, J., Weishaupt, J., & Bahr, M.
Venue
Current Molecular Medicine
Published
2007-03-01
Volume
7
Issue
2
Pages
157-170
ISSN
1566-5240 (ISSN-L)
OpenAlex
W2151381233
Cited by
27
References
0
Citations by year
2025: 1 · 2021: 1 · 2019: 1 · 2017: 2 · 2014: 3 · 2013: 1 · 2012: 2
FWCI
2.96
Type
journal article
Language
en
Open access
closed
Locations
  • Current Molecular Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • GRO (submittedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
  • Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
erythropoietin, granulocyte colony-stimulating factor, hematopoietic growth factors, neuroprotection, stroke, apoptosis inhibition, angiogenesis, neurogenesis, anti-inflammatory activity, neurotrophic effects, central nervous system, neurological disease models, functional outcome
MeSH terms
Animals, Brain, Erythropoietin, Humans, Inflammation, Models, Neurological, Nervous System Diseases, Neurology, Parkinson Disease, Research Design, Signal Transduction, Granulocyte Colony-Stimulating Factor, Apoptosis, Neuroprotective Agents, Neovascularization, Physiologic, Stroke, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hematopoietic Cytokines - on the Verge of Conquering Neurology. https://app.cochat.ai/papers/10.2174/156652407780059186
The paper
Tonges, L., M. Schlachetzki, J., Weishaupt, J., & Bahr, M. (2007). Hematopoietic Cytokines - on the Verge of Conquering Neurology. Current Molecular Medicine. https://doi.org/10.2174/156652407780059186

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.